ангиотензин II-真实生活中的使用和文献综述
Andreja Möller Petrun1,2, Andrej Markota2,3
1Department of Anaesthesiology, Intensive Therapy and Pain Management, University Medical Centre Maribor, 2000 Maribor, Slovenia.
Medicina (Kaunas, Lithuania)
|September 28, 2024
概括
ангиотензин II 是一种新型血管压缩剂,通过激活宁- ангиотензин- 阿尔多斯特系统,有效地管理冲击. 需要进一步的研究来澄清这种重要的治疗剂的最佳使用,组合策略和停药协议.
科学领域:
- 药理学和生理学 药理学和生理学
- 关键护理医学 关键护理医学
背景情况:
- ангиотензин II 是一种新型血管压缩剂,于2017年推出,通过氨酸- ангиотензин- 阿尔多斯特系统起作用.
- 它的新性和成本目前限制了广泛的临床应用.
- 它是唯一一种独特地激活这种途径的血管压缩剂.
研究的目的:
- 审查 ангиотензин II 的生理和病理生理效应.
- 描述 ангиотензин II 的药理学.
- 提供关于血管素II在冲击管理中的当前文献的叙述性综述.
主要方法:
- 关于血管素II现有研究的文献综述.
- 分析生理和病理生理机制.
- 血管素II的药理学描述.
主要成果:
- ангиотензин II 诱导血管收缩并影响其他生理过程.
- 证据支持其用于耐火性血管和心脏性休克.
- 由于数据有限,最佳时间,组合策略和停药协议仍然不清楚.
结论:
- ангиотензин II 是一种有价值的治疗选择,用于特定的冲击状态.
- 需要进一步的研究来优化其临床应用.
- 目前正在进行的研究旨在解决目前关于其使用的不确定性.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
597
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
597
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
490
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
490
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
395
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
395
Antihypertensive Drugs: Direct Renin Inhibitors
506
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
506
Hypertension II: Pathophysiology
2
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
2
Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3


